Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy Versus Radio-Chemotherapy in Localized Low Grade Lymphoma
NCT00536458Phase 3Completed
- Sponsor
- French Innovative Leukemia Organisation
- Start
- Mar 1999
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of cyclophosphamide + doxorubicin + etoposide + prednisone in lymphoma, sponsored by French Innovative Leukemia Organisation. Started Mar 1999; status: completed.
02
Drugs
cyclophosphamide + doxorubicin + etoposide + prednisone
03
Conditions
lymphoma
Beyond the preview
Go deeper on NCT00536458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00536458.